ClinicalTrials.Veeva

Menu

Does Simethicone Improve Operative Field in Gynecological Operations

A

Assiut University

Status and phase

Unknown
Phase 3

Conditions

Benign Gynecologic Neoplasm

Treatments

Drug: Simethicone
Drug: Enema

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Mechanical bowel preparation aims to decrease the volume fecal content in the colon, which thereby decreases the total colony count of bacteria, thus, decreasing peritoneal contamination in case of bowel injury, improving the access to the surgical field and facilitating intraoperative bowel manipulation

Enrollment

90 estimated patients

Sex

Female

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Gynecological operations for benign conditions as hysterectomy, ovarian cystectomy and myomectomy.

Exclusion criteria

  1. History of allergic reaction to study drugs.
  2. More than one scar of previous operation.
  3. Suspicious of malignancy.
  4. Psychiatric disorders.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 2 patient groups

Simethicone
Experimental group
Description:
women take 6 tablets (2 tablets after each meal) and to fast overnight before the operation
Treatment:
Drug: Simethicone
Enema
Active Comparator group
Description:
women take 3 rectal Enema (8:00 pm, 12:00 am \& 8:00 am) and to fast over night before the operation.
Treatment:
Drug: Enema

Trial contacts and locations

1

Loading...

Central trial contact

Altayeb Mostafa, MBBCh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems